Literature DB >> 1540430

Single lung transplantation and pulmonary hypertension.

T Higenbottam.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1540430      PMCID： PMC1024739          DOI： 10.1136/hrt.67.2.121

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  8 in total

1.  Ethics of lung transplantation with live donors.

Authors:  L R Shaw; J D Miller; A S Slutsky; J R Maurer; J D Puskas; G A Patterson; P A Singer
Journal:  Lancet       Date:  1991-09-14       Impact factor: 79.321

2.  Unilateral lung transplantation in end-stage pulmonary emphysema.

Authors:  H Mal; B Andreassian; F Pamela; J P Duchatelle; E Rondeau; F Dubois; P Baldeyrou; M Kitzis; C Sleiman; R Pariente
Journal:  Am Rev Respir Dis       Date:  1989-09

Review 3.  Primary pulmonary hypertension: diagnosis, medical and surgical treatment.

Authors:  A T Dinh Xuan; T W Higenbottam; J P Scott; J Wallwork
Journal:  Respir Med       Date:  1990-05       Impact factor: 3.415

4.  Oxygen relieves breathlessness in "pink puffers".

Authors:  A A Woodcock; E R Gross; D M Geddes
Journal:  Lancet       Date:  1981-04-25       Impact factor: 79.321

5.  Improved survival after heart-lung transplantation.

Authors:  P M McCarthy; V A Starnes; J Theodore; E B Stinson; P E Oyer; N E Shumway
Journal:  J Thorac Cardiovasc Surg       Date:  1990-01       Impact factor: 5.209

6.  Effect of single lung transplantation on pulmonary hypertension in patients with end stage fibrosing lung disease.

Authors:  J C Doig; P A Corris; C J Hilton; J H Dark; R S Bexton
Journal:  Br Heart J       Date:  1991-12

7.  Long-term results, hemodynamics, and complications after combined heart and lung transplantation.

Authors:  K D Dawkins; S W Jamieson; S A Hunt; J C Baldwin; C M Burke; A Morris; M E Billingham; J Theodore; P E Oyer; E B Stinson
Journal:  Circulation       Date:  1985-05       Impact factor: 29.690

8.  High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

Authors:  S Rich; B H Brundage
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.